Behind the Mystery: Diagnosing Endogenous Cushing Syndrome
July 20, 2016
Strongbridge Biopharma: Driven by Passion. Focused on Results.
On today’s special series “Behind the Mystery,” we’re talking about Cushing syndrome, a rare hormonal disorder that is too often misdiagnosed where patients are simply told to lose weight! An estimated 25,000 patients in the United States and 40,000 patients in Europe are currently diagnosed with endogenous Cushing syndrome. Endogenous Cushing syndrome is believed to be underdiagnosed due to lack of disease recognition by the treating physician, which often leads to a delay in diagnosis on average of six years. Host Olga Villaverde will talk with Dr. Maria Fleseriu and patient Leslie Edwin, to raise awareness about Cushing syndrome and discuss symptoms and ways to properly diagnosis it.
The Rockefeller Foundation is working to give communities the food, income, and benefits they need to survive by providing access to various helpful resources.
Homesquare offers an extensive and curated range of functional, stylish, and modern furniture that allows customers to create their dream home office.
The Balancing Act is back, exploring ways to survive and thrive during the coronavirus pandemic – from mental health to creating your dream workspace.